The role of cell adhesion molecules in the pathogenesis of preeclampsia


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

This review analyzes the data available in the current literature on the immunological aspects of the development of preeclampsia (PE) and on the involvement of cell adhesion molecules (CAMs) in its development. It includes the data of foreign and Russian articles found in Pubmed and eLibrary. Despite many studies and theories, the etiology of PE is still unclear. The current idea on the pathogenesis of PE attributed an important role to immunological disorders, resulting in impaired placentation, reduced placental perfusion, and placental ischemia. The increased permeability of the placental barrier and the release of endothelium-damaging substances into blood lead to endothelial dysfunction and a systemic inflammatory response. In turn, these changes affect the function of many organ systems, including the kidney, brain, liver, and heart. The placental barrier separates maternal and fetal blood flows and provides trophic, respiratory, and metabolic functions. CAMs are involved in many processes: immune and inflammatory responses, the formation of intercellular contacts and integrity of the placental barrier, and the regulation of signaling pathways. There is also evidence that CAMs are involved in the pathophysiology of PE, contributing to decreased trophoblast invasion and increased vascular endothelial damage. When the intercellular trophoblast contacts are impaired, the membrane form of CAM passes into a soluble form. The detection of soluble CAM forms can be of prognostic and diagnostic value. Conclusion. Studying CAMs will allow a more accurate assessment of the severity and a higher reliability in predicting the outcome of pregnancy complicated by PE.

Негізгі сөздер

Толық мәтін

Рұқсат жабық

Авторлар туралы

Artemiy Shelekhin

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia; I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia

Email: dr.shelekhin@gmail.com
postgraduate student

Oleg Baev

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia; I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia

Email: o_baev@oparina4.ru
Dr. Med. Sci., Professor, Head of the 1st Maternity Department

Alexey Krasnyi

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: a_krasnyi@oparina4.ru
PhD, Head of the Cytology Laboratory

Әдебиет тізімі

  1. Адамян Л.В., Артымук Н.В., Башмакова Н.В., Белокринницкая Т.Е., Беломестное С.Р., Братищев И.В., Вученович Ю.Д., Краснопольский В.И., Куликов А.В., Левит А.Л., Никитина Н.А., Петрухин В.А., Пырегов А.В., Серов В.Н., Сидорова И.С., Филиппов О. С., Ходжаева З.С., Холин А.М., Шешко Е.Л., Шифман Е.М., Шмаков Р.Г. Гипертензивные расстройства во время беременности, в родах и послеродовом периоде. Преэклампсия. Эклампсия. Клинические рекомендации (Протокол лечения). М.; 2016.
  2. Савельева Г.М., Сухих Г.Т., Серов В.Н., Радзинский В.Е., ред. Акушерство. Национальное руководство. М.: ГЭОТАР-Медиа; 2015.
  3. Cnattingius S., Reilly M., Pawitan Y., Lichtenstein P. Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population-based Swedish cohort study. Am. J. Med. Genet. A. 2004; 130A(4): 365-71. https://dx.doi.org/10.1002/ajmg.a.30257.
  4. Стрижаков А.Н., Игнатко И.В., Давыдов А.И. Акушерство. Учебник. М.: ГЭОТАР-Медиа; 2020.
  5. Зиганшина М.М., Кречетова Л.В., Ванько Л.В., Культербаева М.А., Соколян А.В., Сухих Г.Т. Динамика растворимых форм молекул клеточной адгезии при преэклампсии. Акушерство и гинекология. 2011; 2: 42-8.
  6. Haram K., Mortensen J.H., Myking O., Magann E.F., Morrison J.C. The role of oxidative stress, adhesion molecules and antioxidants in preeclampsia. Curr. Hypertens Rev. 2019; 15(2): 105-12. https://dx.doi.org/10.2174/1573402115666190119163942.
  7. Сидорова И.С. Преэклампсия. М.: МИА; 2016. 522c.
  8. Jim B., Karumanchi S.A. Preeclampsia: pathogenesis, prevention, and long-term complications. Semin. Nephrol. 2017; 37(4): 386-97. https://dx.doi.org/10.1016/j.semnephrol.2017.05.011.
  9. Chaiworapongsa T., Chaemsaithong P., Yeo L., Romero R. Preeclampsia part 1: current understanding of its pathophysiology. Nat. Rev. Nephrol. 2014; 10(8): 466-80. https://dx.doi.org/10.1038/nrneph.2014.102.
  10. Сухих Г.Т., Мурашко Л.Е., ред. Преэклампсия. Руководство. М.: ГЭОТАР-Медиа; 2010. 586 c.
  11. Bowen R.S., Moodley J., Dutton M.F., Fickl H. Systemic inflammatory indices in pre-eclampsia and eclampsia. J. Obstet. Gynaecol. 2001; 21(6): 563-9. https://dx.doi.org/10.1080/01443610120085483.
  12. Filip M., Maciag J., Nosalski R., Korbut R., Guzik T. Endothelial dysfunction related to oxidative stress and inflammation in perivascular adipose tissue. Postepy Biochem. 2012; 58(2): 186-94.
  13. De Ciuceis C., Rossini C., La Boria E., Porteri E., Petroboni B., Gavazzi A. et al. Immune mechanisms in hypertension. High Blood Press. Cardiovasc. Prev. 2014; 21(4): 227-34. https://dx.doi.org/10.1007/s40292-014-0040-9.
  14. Карапетян А.О., Красный А.М., Садекова А.А., Хлестова Г.А., Балашов И.С., Баев О.Р. Изменение концентрации внеклеточной ДНК во время беременности. Акушерство и гинекология. 2018; 3: 44-50.
  15. Redman C.W.G., Sargent I.L. Immunology of pre-eclampsia. Am. J. Reprod. Immunol. 2010; 63(6): 534-43. https://dx.doi.org/10.1111/j.1600-0897.2010.00831.x.
  16. LeMaoult J., Le Discorde M., Rouas-Freiss N., Moreau P., Menier C., McCluskey J., Carosella E.D. Biology and functions of human leukocyte antigen-G in health and sickness. Tissue Antigens. 2003; 62(4): 273-84. https://dx.doi.org/10.1034/j.1399-0039.2003.00143.x.
  17. Liang H., Zhang Q., Lu J., Yang G., Tian N., Wang X., Tan Y., Tan D. MSX2 induces trophoblast invasion in human placenta. PLoS One. 2016; 11(4): e0153656. https://dx.doi.org/10.1371/journal.pone.0153656.
  18. Vestweber D. Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium. Immunol. Rev. 2007; 218: 178-96. https://dx.doi.org/10.1111/j.1600-065X.2007.00533.x.
  19. Walzog B., Gaehtgens P. Adhesion molecules: the path to a new understanding of acute inflammation. News Physiol. Sci. 2000; 15: 107-13. https://dx.doi.org/10.1152/physiologyonline.2000.15.3.107.
  20. Красный А.М., Хачатурян А.А., Кан Н.Е., Хачатрян З.В., Тютюнник В.Л., Волгина Н.Е., Ганичкина М.Б., Мантрова Д.А., Садекова А.А. Роль Е-кадгерина в формировании задержки роста плода. Акушерство и гинекология. 2018; 6: 38-43. https://dx.doi.org/10.18565/aig.2018.6.38-43.
  21. Fernekorn U., Butcher E.C., Behrends J., Karsten C.M., Robke A., Schulze T.J., Kirchner H., Kruse A. Selectin, platelet plays a critical role in granulocyte access to the pregnant mouse uterus under physiological and pathological conditions. Biol. Reprod. 2007; 76(4): 645-53. https://dx.doi.org/10.1095/biolreprod.106.056192.
  22. Bonello N., Norman R.J. Soluble adhesion molecules in serum throughout the menstrual cycle. Hum. Reprod. 2002; 17(9): 2272-8. https://dx.doi.org/10.1093/humrep/17.9.2272.
  23. Kyama C.M., Overbergh L., Mihalyi A., Meuleman C., Mwenda J.M., Mathieu C., D’Hooghe T.M. Endometrial and peritoneal expression of aromatase, cytokines, and adhesion factors in women with endometriosis. Fertil. Steril. 2008; 89(2): 301-10. https://dx.doi.org/10.1016/j.fertnstert.2007.02.057.
  24. Margarit L., Gonzalez D., Lewis P.D., Hopkins L., Davies C., Conlan R.S., Joels L., White J.O. L-selectin ligands in human endometrium: comparison of fertile and infertile subjects. Hum. Reprod. 2009; 24(11): 2767-77. https://dx.doi.org/10.1093/humrep/dep247.
  25. Docheva N., Romero R., Chaemsaithong P., Tarca A.L., Bhatti G., Pacora P. et al. The profiles of soluble adhesion molecules in the “great obstetrical syndromes.” J. Matern. Neonatal Med. 2019; 32(13): 2113-36. https://dx.doi.org/10.1080/14767058.2018.1427058.
  26. Guillard C., Zidi I., Marcou C., Menier C., Carosella E.D., Moreau P. Role of HLA-G in innate immunity through direct activation of NF-kappaB in natural killer cells. Mol. Immunol. 2008; 45(2): 419-27. https://dx.doi.org/10.1016/j.molimm.2007.06.160.
  27. Darmochwal-Kolarz D., Saito S., Rolinski J., Tabarkiewicz J., Kolarz B., Leszczynska-Gorzelak B., Oleszczuk J. Activated T. lymphocytes in pre-eclampsia. Am. J. Reprod. Immunol. 2007; 58(1): 39-45. https://dx.doi.org/10.1111/j.1600-0897.2007.00489.x.
  28. Kim S.Y., Ryu H.M., Yang J.H., Kim M.Y., Ahn H.K., Lim H.J. et al. Maternal serum levels of VCAM-1, ICAM-1 and E-selectin in preeclampsia. J. Korean Med. Sci. 2004; 19(5): 688-92. https://dx.doi.org/10.3346/jkms.2004.19.5.688.
  29. Nagamatsu T., Schust D.J. The immunomodulatory roles of macrophages at the maternal-fetal interface. Reprod. Sci. 2010; 17(3): 209-18. https://dx.doi.org/10.1177/1933719109349962.
  30. Vestweber D., Winderlich M., Cagna G., Nottebaum A.F. Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player. Trends Cell Biol. 2009; 19(1): 8-15. https://dx.doi.org/10.1016Zj.tcb.2008.10.001.
  31. Aydin S., Benian A., Madazli R., Uludag S., Uzun H., Kaya S. Plasma malondialdehyde, superoxide dismutase, sE-selectin, fibronectin, endothelin-1 and nitric oxide levels in women with preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 2004; 113(1): 21-5. https://dx.doi.org/10.1016/S0301-2115(03)00368-3.
  32. Nadar S.K., Al Yemeni E., Blann A.D., Lip G.Y.H. Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/ dysfunction and activation in pregnancy induced hypertension. Thromb. Res. 2004; 113(2): 123-8. 10.1016/j.thromres.2004.02.010.
  33. Chavarria M.E., Lara-Gonzalez L., Garcia-Paleta Y., Vital-Reyes V.S., Reyes A. Adhesion molecules changes at 20 gestation weeks in pregnancies complicated by preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 2008; 137(2): 157-64. https://dx.doi.org/10.1016/j.ejogrb.2007.06.014.
  34. Papakonstantinou K., Economou E., Koupa E., Babameto I., Hasiakos D., Vitoratos N. Antepartum and postpartum maternal plasma levels of E-selectin and VE-cadherin in preeclampsia, gestational proteinuria and gestational hypertension. J. Matern. Fetal Neonatal Med. 2011; 24(8): 1027-32. https://dx.doi.org/10.3109/14767058.2010.545907.
  35. Li X.L., Dong X., Xue Y., Li C.F., Gou W.L., Chen Q. Increased expression levels of E-cadherin, cytokeratin 18 and 19 observed in preeclampsia were not correlated with disease severity. Placenta. 2014; 35(8): 625-31. https://dx.doi.org/10.1016/j.placenta.2014.04.010.
  36. Huppertz B., Kingdom J., Caniggia I., Desoye G., Black S., Korr H., Kaufmann P. Hypoxia favours necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulation. Placenta. 2003; 24(2-3): 181-90. https://dx.doi.org/10.1053/plac.2002.0903.
  37. Correa R.R.M., Gilio D.B., Cavellani C.L., Paschoini M.C., Oliveira F.A., Peres L.C. et al. Placental morphometrical and histopathology changes in the different clinical presentations of hypertensive syndromes in pregnancy. Arch. Gynecol. Obstet. 2008; 277(3): 201-6. https://dx.doi.org/10.1007/s00404-007-0452-z.
  38. Li H.W., Cheung A.N.Y., Tsao S.W., Cheung A.L.M., O. W.S. Expression of e-cadherin and beta-catenin in trophoblastic tissue in normal and pathological pregnancies. Int. J. Gynecol. Pathol. 2003; 22(1): 63-70. https://dx.doi.org/10.1097/00004347-200301000-00013.
  39. Brown L.M., Lacey H.A., Baker P.N., Crocker I.P. E-cadherin in the assessment of aberrant placental cytotrophoblast turnover in pregnancies complicated by pre-eclampsia. Histochem. Cell Biol. 2005; 124(6): 499-506. https://dx.doi.org/10.1007/s00418-005-0051-7.
  40. Blechschmidt K., Kremmer E., Hollweck R., Mylonas I., Hofler H., Kremer M., Becker K.-F. The E-cadherin repressor snail plays a role in tumor progression of endometrioid adenocarcinomas. Diagn. Mol. Pathol. 2007; 16(4): 222-8. https://dx.doi.org/10.1097/PDM.0b013e31806219ae.
  41. Xu B., Nakhla S., Makris A., Hennessy A. TNF-а inhibits trophoblast integration into endothelial cellular networks. Placenta. 2011; 32(3): 241-6. 10.1016/j. placenta.2010.12.005.
  42. Szarka A., Rigo J., Lazar L., Beko G., Molvarec A. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol. 2010; 11: 59. https://dx.doi.org/10.1186/1471-2172-11-59.
  43. Farzadnia M., Ayatollahi H., Hasan-Zade M., Rahimi H.R. A comparative study of vascular cell adhesion molecule-1 and high-sensitive C-reactive protein in normal and preeclamptic pregnancies. Interv. Med. Appl. Sci. 2013; 5(1): 26-30. https://dx.doi.org/10.1556/IMAS.5.2013.1.5.
  44. Bilodeau J.-F. Review: maternal and placental antioxidant response to preeclampsia - impact on vasoactive eicosanoids. Placenta. 2014; 35(Suppl.): S32-8. https://dx.doi.org/10.1016/j.placenta.2013.11.013.
  45. Anderson M.E., Siahaan T.J. Targeting ICAM-1/LFA-1 interaction for controlling autoimmune diseases: designing peptide and small molecule inhibitors. Peptides. 2003; 24(3): 487-501. https://dx.doi.org/10.1016/s0196-9781(03)00083-4.
  46. Juliano P.B., Blotta M.H.S.L., Altemani A.M.A. ICAM-1 is overexpressed by villous trophoblasts in placentitis. Placenta. 2005; 27(6-7): 750-7. https://dx.doi.org/10.1016/j.placenta.2005.07.008.
  47. Goksu Erol A.Y., Nazli M., Elis Yildiz S. Significance of platelet endothelial cell adhesion molecule-1 (PECAM-1) and intercellular adhesion molecule-1 (ICAM-1) expressions in preeclamptic placentae. Endocrine. 2012; 42(1): 125 31. https://dx.doi.org/10.1007/s12020-012-9644-9
  48. Krauss T., Emons G., Kuhn W., Augustin H.G. Predictive value of routine circulating soluble endothelial cell adhesion molecule measurements during pregnancy. Clin. Chem. 2002; 48(9): 1418-25

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Bionika Media, 2021

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>